Question 63

The prescription appears to contain a look-alike/sound-alike error.

The pharmacy technician should alert the pharmacist because lamivudine is not typically indicated for seizures, which raises the possibility of a look-alike/sound-alike error in the medication prescribed.

A) the prescription appears to contain a look-alike/sound-alike error

This option is correct as lamivudine is primarily used for the treatment of HIV and chronic hepatitis B, not for seizures. The technician's alertness to this discrepancy suggests that the prescription may have been intended for a different medication, such as lamotrigine, which is used for seizure management.

B) lamivudine requires special handling

This option is incorrect because lamivudine does not have specific special handling requirements that would necessitate alerting the pharmacist. It is a standard oral medication without unique handling protocols.

C) the prescription exceeds the maximum recommended daily dose

This option is also incorrect. The prescribed dose of lamivudine at 100 mg once a day does not exceed the maximum recommended daily dose for its approved indications, which further emphasizes the need to check the medication's appropriateness for seizures.

D) lamivudine is subject to a REMS program

This option is incorrect as well. Lamivudine is not classified under any Risk Evaluation and Mitigation Strategies (REMS) program, which would require special monitoring or restrictions, making this reason invalid in the context of this prescription.

Conclusion

The correct answer is option A, as it highlights the critical need for vigilance in medication dispensing, especially when a drug is prescribed for an off-label use. The other options fail to address the primary concern of the medication's appropriateness for the stated condition, reinforcing the importance of ensuring accurate medication therapy management.